clinical trial · NCT07848334
First-in-Human Safety and Tolerability Study of OPF-110 in Healthy Adults
Otsuka Pharmaceutical Factory, Inc.·phase1·active not recruiting·n = 24
Healthy VolunteersOPF-110SMOFLIPID
brief summary
This study will evaluate the safety and tolerability of OPF-110 in healthy adult participants.
started
Aug 12, 2026
primary completion
Oct 1, 2026
completion
Oct 1, 2026
last updated
Oct 19, 2026
official title
A Phase 1, First-in-human, Randomized, Single-blind, Active-controlled, 2-arm, Parallel-group, Single Ascending Dose Study to Evaluate the Safety and Tolerability of OPF-110 in Healthy Adult Participants.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol